title: Managing the transition to CFC-free inhalers.
abstract: Asthma inhalers which use CFC propellants will be replaced by CFC-free devices within three years. Research suggests that inflammation in the small airways is often inadequately treated. CFC-free steroid-based inhalers appear to increase total lung deposition and peripheral lung penetration.
authors.affiliation: Respiratory Centre, Portsmouth NHS Trust Hospitals.
authors.forename: C
authors.initials: C
authors.lastname: Fehrenbach
mesh_terms: D000280:Administration, Inhalation; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology / Q000451:nursing; D017402:Chlorofluorocarbons; D006801:Humans; D007249:Inflammation; D009330:Nebulizers and Vaporizers; D010353:Patient Education as Topic; D013256:Steroids
chemical_list: D000893:Anti-Inflammatory Agents; D017402:Chlorofluorocarbons; D013256:Steroids